Updated Jul 16, 2026
Jain Vivek has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $2.47M. Lifetime open-market sales: $6.16M.
Vivek Jain is the Chairman and CEO of ICU Medical, a leading company in the infusion therapy sector. Under his leadership, ICU Medical has expanded significantly, notably through the acquisition of Hospira Infusion Systems and Smiths Medical.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | NVST | Envista Holdings Corp | A — Grant or award | 9.3K | $0.00 | |
| 2026-03-16 | ICUI | ICU MEDICAL INC/DE | F — Tax withholding / forfeiture | 2.7K | $125.85 | $339K |
| 2026-03-16 | ICUI | ICU MEDICAL INC/DE | M — Option exercise | 4.9K | $0.00 | |
| 2026-03-16 | ICUI | ICU MEDICAL INC/DE | F — Tax withholding / forfeiture | 9.5K | $125.85 | $1.19M |
| 2026-03-16 | ICUI | ICU MEDICAL INC/DE | M — Option exercise | 17.1K | $0.00 | |
| 2026-03-09 | ICUI | ICU MEDICAL INC/DE | F — Tax withholding / forfeiture | 59.5K | $132.00 | $7.85M |
| 2026-03-09 | ICUI | ICU MEDICAL INC/DE | M — Option exercise | 107.6K | $0.00 | |
| 2026-03-09 | ICUI | ICU MEDICAL INC/DE | F — Tax withholding / forfeiture | 2.9K | $0.00 | |
| 2026-03-09 | ICUI | ICU MEDICAL INC/DE | M — Option exercise | 5.3K | $0.00 | |
| 2025-09-12 | ICUI | ICU MEDICAL INC/DE | G — Bona-fide gift | 63.6K | $0.00 | |
| 2025-09-12 | ICUI | ICU MEDICAL INC/DE | G — Bona-fide gift | 63.6K | $0.00 | |
| 2025-08-14 | ICUI | ICU MEDICAL INC/DE | P — Open-market purchase | 19.6K | $112.92 | $2.21M |
| 2025-08-14 | ICUI | ICU MEDICAL INC/DE | P — Open-market purchase | 2.4K | $112.12 | $267K |
| 2024-12-02 | ICUI | ICU MEDICAL INC/DE | S — Open-market sale [10b5-1] | 78 | $163.96 | $13K |
| 2024-12-02 | ICUI | ICU MEDICAL INC/DE | S — Open-market sale [10b5-1] | 8.2K | $163.18 | $1.35M |
| 2024-12-02 | ICUI | ICU MEDICAL INC/DE | S — Open-market sale [10b5-1] | 3.7K | $162.29 | $596K |
| 2024-12-02 | ICUI | ICU MEDICAL INC/DE | M — Option exercise [10b5-1] | 12.0K | $88.76 | $1.07M |
| 2024-11-04 | ICUI | ICU MEDICAL INC/DE | S — Open-market sale [10b5-1] | 1.2K | $173.60 | $215K |
| 2024-11-04 | ICUI | ICU MEDICAL INC/DE | S — Open-market sale [10b5-1] | 2.4K | $172.76 | $412K |
| 2024-11-04 | ICUI | ICU MEDICAL INC/DE | S — Open-market sale [10b5-1] | 4.1K | $171.91 | $713K |
Vivek Jain is the Chairman and CEO of ICU Medical, a leading company in the infusion therapy sector. Under his leadership, ICU Medical has expanded significantly, notably through the acquisition of Hospira Infusion Systems and Smiths Medical.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($2.47M) and 11 open-market sales ($6.16M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jain Vivek profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.